enow.com Web Search

  1. Ads

    related to: eye prism correction device for macular degeneration

Search results

    15.32-0.15 (-0.97%)

    at Tue, Jun 4, 2024, 4:00PM EDT - U.S. markets closed

    Nasdaq Real Time Price

    • Open 15.29
    • High 15.50
    • Low 15.12
    • Prev. Close 15.47
    • 52 Wk. High 27.02
    • 52 Wk. Low 13.71
    • P/E N/A
    • Mkt. Cap 1.22B
  1. Results from the WOW.Com Content Network
  2. Retinal implant - Wikipedia

    en.wikipedia.org/wiki/Retinal_implant

    A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD).

  3. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/fda-approves-biosimilars-macular...

    The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related macular degeneration, diabetic retinopathy and other eye conditions. Biosimilars Yesafili and Opuviz...

  4. Visual prosthesis - Wikipedia

    en.wikipedia.org/wiki/Visual_prosthesis

    A visual prosthesis, often referred to as a bionic eye, is an experimental visual device intended to restore functional vision in those with partial or total blindness. Many devices have been developed, usually modeled on the cochlear implant or bionic ear devices, a type of neural prosthesis in use since the mid-1980s.

  5. Metamorphopsia - Wikipedia

    en.wikipedia.org/wiki/Metamorphopsia

    Metamorphopsia can be a symptom of a number of eye disorders involving the retina or macula. Some of these conditions include the following: Age-related macular degeneration; Epiretinal membrane and vitreomacular traction; Posterior vitreous detachment; Macular hole; Diagnosis

  6. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

    www.aol.com/merck-acquire-eye-drug-company...

    (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.

  7. How to reduce risks of macular degeneration - AOL

    www.aol.com/lifestyle/actress-judi-dench-says...

    Macular degeneration happens with age, when the macula, at the center of the retina — “the part of the eye that sees the world for us,” Dr. Vlad Diaconita, a retinal and vitreoretinal ...